id: homelessness_rate_to_hepatitis_c_prevalence
name: Homelessness â†’ Hepatitis C Prevalence
from_node:
  node_id: homelessness_rate
  node_name: Homelessness
to_node:
  node_id: hepatitis_c_prevalence
  node_name: Hepatitis C Prevalence
direction: positive
category: social_environment
mechanism_pathway:
- 'Step 1: Homelessness creates conditions of housing instability, limiting access
  to safe hygiene facilities and private spaces for health practices'
- 'Step 2: People experiencing homelessness have elevated rates of injection drug
  use (21% prevalence in homeless-only populations) as a coping mechanism and due
  to co-occurring substance use disorders'
- 'Step 3: Injection drug use in unstable housing conditions leads to increased needle
  sharing and use of non-sterile injection equipment'
- 'Step 4: High-risk injection practices combined with limited healthcare access result
  in elevated HCV transmission and seroprevalence (20% pooled prevalence in homeless-only
  populations)'
- 'Step 5: Barriers to healthcare access, treatment adherence, and continuity of care
  among homeless populations allow HCV infection to persist and spread within this
  community'
evidence:
  quality_rating: A
  n_studies: 39
  primary_citation: 'A Hashim et al. 2021. Community-Based Assessment and Treatment
    of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst
    People Who Are Homeless: A Systematic Review and Meta-Analysis. The International
    journal on drug policy.'
  supporting_citations: []
description: This systematic review and meta-analysis of 39 studies demonstrates that
  people who are homeless have substantially elevated HCV seroprevalence (20% pooled
  estimate in homeless-only populations, range 2.5%-58% across all studies). The pathway
  operates primarily through elevated injection drug use rates (21% in homeless populations),
  which facilitates HCV transmission through needle sharing. Additional contributing
  factors include high rates of alcohol use (59%), limited access to screening and
  treatment services, and barriers to healthcare engagement. Despite these challenges,
  when community-based treatment is provided, SVR rates of 92% are achievable.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 20.0
    type: prevalence_percentage
    ci_lower: 12.0
    ci_upper: 30.0
  p_value: null
  sample_size: 13918
moderators:
- name: Injection drug use
  direction: strengthens
  strength: strong
  description: IDU prevalence ranged 7%-73% across studies; 21% in homeless-only populations,
    serving as primary transmission mechanism for HCV
- name: Alcohol use
  direction: strengthens
  strength: moderate
  description: Alcohol use prevalence was 59% in homeless-only populations, contributing
    to liver disease progression and potentially risk behaviors
- name: Access to community-based interventions
  direction: weakens
  strength: moderate
  description: RCTs showed community-based interventions significantly increased linkage
    to care and HCV treatment/cure rates
